| Pharmaceutical Information |
| Drug Name |
Aminolevulinic acid hydrochloride |
| Drug ID |
BADD_D00111 |
| Description |
A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem] |
| Indications and Usage |
Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp. |
| Marketing Status |
approved |
| ATC Code |
L01XD04 |
| DrugBank ID |
DB00855
|
| KEGG ID |
D02908
|
| MeSH ID |
D000622
|
| PubChem ID |
123608
|
| TTD Drug ID |
D0O4GY
|
| NDC Product Code |
67308-101; 70621-101; 59137-231; 71956-001 |
| UNII |
V35KBM8JGR
|
| Synonyms |
Aminolevulinic Acid | Acid, Aminolevulinic | Delta-Aminolevulinic Acid | Acid, Delta-Aminolevulinic | Delta Aminolevulinic Acid | Levulan | 5-Aminolaevulinate | 5 Aminolaevulinate | 5-Aminolevulinate | 5 Aminolevulinate | Aminolevulinic Acid Hydrochloride | Acid Hydrochloride, Aminolevulinic | Hydrochloride, Aminolevulinic Acid |
|
| Chemical Information |
| Molecular Formula |
C5H10ClNO3 |
| CAS Registry Number |
5451-09-2 |
| SMILES |
C(CC(=O)O)C(=O)CN.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
